Simplified Treatment of Anti-retrovirus in China (C-STAR)
ConditionHIV/AIDS
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGuangzhou 8th People's Hospital
About this trial
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
Eligibility criteria
Qualifiers
HIV-1 infection confirmed
Agree to use simplified therapy regimen.
Agree to detect CD4 count at least once per half a year
Disqualifiers
Have participated in HIV vaccine clinical trial or other drug trials in the past three months.
Patients who could not complete the scheduled follow-up (such as weakness and poor compliance).
Patients who have the history of resistance or allergy to LPV/r or 3TC.
Trial design
Treatments tested in this trial
- Lpv/r+3TC
Treatment groups
600 Participants
are divided into 1 treatment groupSponsors and collaborators
Guangzhou 8th People's Hospital
Lead sponsor
Guiyang Public Health Clinical Center
Collaborator
The Third People's Hospital of Kunming
Collaborator
The Second People's Hospital of Nanjing
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborator
The Third People's Hospital of Guilin
Collaborator
Guangxi Longtan hospital
Collaborator
The Fourth People's Hospital of Nanning
Collaborator
LiuZhou People's Hospital
Collaborator
Tianjin Second People's Hospital
Collaborator
Shenyang Sixth People's Hospital
Collaborator
The Sixth People's Hospital of Henan
Collaborator
The Sixth People's Hospital of Xinjiang
Collaborator
The Eighth People's Hospital of Xi'an
Collaborator
Source ClinicalTrials.gov